Toe Implant Lawsuit News
Consolidated Federal Action · N.D. Georgia · 2025–2026

Toe Implant Lawsuit News:
New 2025–2026 Developments in Failed Joint Implants

A major consolidated action is underway in the Northern District of Georgia, with motions to dismiss denied and discovery into failure-rate data and implant migration now ordered. State coordinated proceedings are active in Georgia, Texas, and California. Our firm is accepting cases nationwide.

Toe implants — including Cartiva synthetic cartilage implants, silicone toe implants, and metallic joint-replacement devices — were marketed to patients with hallux rigidus and other degenerative toe conditions as long-lasting, low-risk solutions. Instead, thousands of patients have experienced implant loosening, fragmentation, bone loss, severe pain, and the need for complex revision surgery. Plaintiffs allege manufacturers underreported failure rates, concealed known migration and wear risks, and failed to warn the surgeons who relied on their representations.
N.D. Ga. Lead consolidated federal action
MTD Denied Defective design & failure-to-warn claims proceeding
Active Discovery into failure rates & migration data ordered
3 States Coordinated proceedings: GA, TX, CA

Where the Litigation Stands Now

The consolidated federal action in the Northern District of Georgia is now in active discovery following denial of the defendants’ motions to dismiss. The court’s discovery orders are targeting the internal data manufacturers had about failure rates and implant behavior that was never disclosed to surgeons or patients.

In re: Cartiva Toe Implant Products Liability Litigation

Case No. 1:25-cv-01422 — Northern District of Georgia

Several motions to dismiss targeting defective design and failure-to-warn claims have been denied. The court has ordered production of failure-rate data, discovery into implant migration and fragmentation, and issued expert-witness scheduling orders. State coordinated proceedings in Georgia, Texas, and California are also active.

Court-Ordered Discovery Includes:

  • Failure-rate data — internal records of the rate at which implants loosened, fragmented, or required revision across product lines and implant sizes
  • Implant migration and fragmentation records — documentation of known patterns of device movement and material breakdown within the joint
  • Expert-witness scheduling — orthopedic and biomechanical experts on implant failure mechanisms are being scheduled for the evidentiary record
Failure-rate data is the key evidence. If manufacturers possessed internal data showing implant loosening and migration rates higher than what was disclosed to surgeons, that evidence will be central to proving both defective design and failure-to-warn claims. This discovery is underway now.

Which Toe Implants Are Involved?

The litigation focuses on three categories of implants used to treat hallux rigidus and other degenerative toe conditions. Each involves different materials and failure mechanisms, but all share allegations of underreported failure rates and inadequate surgeon warnings.

Cartiva ImplantsSynthetic cartilage (polyvinyl alcohol)
Silicone Toe ImplantsFlexible silicone joint replacements
Metallic Joint ReplacementsFirst MTP joint arthroplasty devices

How Toe Implants Failed & What Manufacturers Concealed

Plaintiffs allege a pattern of device failures combined with manufacturer conduct that kept true failure rates hidden from the orthopedic surgeons who implanted these devices.

Implant Loosening

Devices loosened from the bone over time, causing painful movement within the joint, instability, and loss of the function the implant was meant to restore.

Fragmentation & Wear

Implant material fragmented or shed particulate debris into the surrounding tissue, causing chronic inflammation, bone erosion, and synovitis.

Migration

Devices migrated from their implanted position within the joint, disrupting biomechanics, causing adjacent bone damage, and complicating any subsequent revision surgery.

Bone Loss

Particulate debris and inflammatory response from failing implants led to osteolysis — progressive bone loss — that has left some patients without adequate bone stock for revision procedures.

Underreported Failure Rates

Plaintiffs allege manufacturers possessed internal data showing failure rates higher than publicly disclosed, and that this data was not shared with surgeons making implant selection decisions.

Failure to Warn of Migration & Wear

Surgeons were not adequately warned about the risk of implant migration and material wear, leaving them unable to counsel patients on realistic long-term outcomes or monitor for early failure signs.

Are You a Victim? Who May Qualify?

You may qualify if you received a Cartiva, silicone, or metallic toe implant and subsequently experienced complications requiring additional treatment, hospitalization, or revision surgery.

Qualifying Complications

  • Chronic pain at the implant site
  • Implant loosening or instability
  • Bone erosion or osteolysis
  • Inflammation or synovitis from implant debris
  • Implant migration within the joint
  • Revision or removal surgery required
  • Loss of mobility or permanent disability

General Eligibility Factors

  • Received a Cartiva, silicone, or metallic toe joint implant
  • Implant placed for hallux rigidus or another degenerative toe condition
  • Experienced a qualifying complication after implantation
  • Complication documented in medical or surgical records
  • Required additional treatment or revision surgery

Liability & What You Can Recover

Liability Legal Theories

  • Defective design
  • Manufacturing defect
  • Failure to warn
  • Negligent misrepresentation
  • Fraudulent concealment of failure data
  • Breach of warranty

Damages What You Can Recover

  • Medical expenses including revision surgery
  • Lost income and reduced earning capacity
  • Compensation for permanent disability
  • Pain and suffering
  • Emotional distress
  • Loss of mobility and quality of life

Our Firm Is Now Accepting Toe Implant Cases

We represent patients nationwide harmed by failed toe implants. We track every development in the Northern District of Georgia consolidated action and state coordinated proceedings in Georgia, Texas, and California — to ensure our clients are best positioned as discovery produces the internal failure data at the heart of these cases.

We handle these cases on a contingency fee basis — you pay nothing unless we win.

This page is for informational purposes only and does not constitute legal advice. Results in prior cases do not guarantee similar outcomes. Consult a qualified attorney for advice specific to your situation.
Our Firm Is Now Accepting Toe Implant Cases Free & confidential case evaluation — you pay nothing unless we win.
Get Your Free Case Evaluation